Table 5.

COPD outcomes according to main morbidities

	At least 2 comorbidities			Overweight-Obese			Hypertension			Type II Diabetes Mellitus			Dyslipidaemia			Heart Diseases
COPD outcome	present	absent	p-value	present	absent	p-value	present	absent	p-value	present	absent	p-value	present	absent	p-value	present	absent	p-value
At least 2 exacerbations in the last 12 months	58 (38)	19 (37)	0.999	61 (36)	16 (49)	0.239	63 (42)	14 (25)	0.037	11 (58)	66 (35)	0.081	13 (29)	64 (40)	0.259	12 (48)	65 (36)	0.332
CAT ≥ 10	13 (7)	8 (15)	0.095	19 (10)	3 (8)	0.776	164 (92)	58 (88)	0.436	26 (96)	197 (91)	0.484	57 (93)	166 (90)	0.613	30 (97)	193 (90)	0.326
mMRC ≥ 2	113 (61)	34 (61)	0.999	127 (64)	21 (48)	0.077	113 (61)	39 (57)	0.660	21 (75)	132 (59)	0.151	31 (50)	122 (64)	0.073	24 (75)	128 (58)	0.109
GOLD 2019-C&D status CAT-based	60 (40)	18 (37)	0.739	64 (38)	14 (45)	0.548	64 (43)	14 (26)	0.023	13 (62)	65 (36)	0.031	15 (33)	63 (40)	0.395	13 (52)	65 (36)	0.186
GOLD 2019-C&D status mMRC-based	60 (40)	19 (37)	0.869	63 (37)	16 (49)	0.245	65 (43)	14 (26)	0.024	13 (62)	66 (36)	0.031	15 (33)	63 (40)	0.395	13 (50)	66 (37)	0.200

Cell values are presented as n (% of COPD outcome within morbidity status) of subjects with COPD outcome in each comorbid condition group and P-values are given by Chi-square test. Bold faceted text indicates P-values< 0.05. COPD Chronic obstructive pulmonary disease, GOLD 2019 Global Initiative for Obstructive Lung Disease 2019 Guidelines, CAT Chronic Obstructive Pulmonary Disease Assessment Test, mMRC Modified Medical Research Council Dyspnoea Scale